660 - Early Experience with Use of Pemivibart for the Pre-exposure Prophylaxis of Coronavirus Disease 2019

Presenting Author(s)

• 

  Brian S. Metzger, MD, MPH

  Partner
  Austin Infectious Disease Consultants
  Austin, Texas, United States

  Slides

Co-Author(s)

• JB

  Jorge R. Bernett, MD

  Physician
  Infectious Disease Doctors Medical Group, APC
  Walnut Creek, California, United States
• 

  Kimberly A. Couch, PharmD, MA, FIDSA, FASHP, HIVPCP, HIVPCPRX, HIVPNC

  Clinical Pharmacist
  Healix
  Stevensville, MD, United States
• 

  Lucinda J. Van Anglen, PharmD, FIDSA

  VP of Clinical Pharmacy & Research
  Healix Infusion Therapy, LLC
  Sugar Land, Texas, United States